|
RCKT Rocket Pharmaceuticals Inc 1281895 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$123,214,000.00 |
| Balance Sheet |
|
Current Assets
|
$289,550,000.00 |
|
Assets
|
$423,098,000.00 |
|
Current Liabilities
|
$31,320,000.00 |
|
Liabilities
|
$54,268,000.00 |
|
Equity
|
$368,830,000.00 |
|
Shares Out
|
109539424.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-85,007,000.00 |
|
Investing Cash Flow
|
$231,808,000.00 |
| Market Analysis |
Market Cap
|
$381,197,195.52 |
|
Price
|
$3.48 |
|
BVPS
|
3.37 |
|
PB
|
1.03 |
|
EPS
|
1.09 |
|
FCF
|
$-85,108,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:33 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.38 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.42 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.62 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.45 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RCKT documents filed with the SEC.
RCKT Filings
Clear
